Hanmi Science Co.,Ltd, formerly Hanmi Holdings Co., Ltd., is a Korea-based holding company engaged in the holdings, business support, management advisory and consulting business. As of December 31, 2011, the Company had four subsidiaries: Hanmi Pharmaceutical Co., Ltd., Ere Murese Co., Ltd., Japan Hanmi Pharmaceutical Co., Ltd and Hanmi Europe Ltd. Its main subsidiary, Hanmi Pharmaceutical Co., Ltd., engaged in the manufacture of pharmaceuticals, such as antidepressants, obesity drugs, oral care drugs, schizophrenia drugs, diabetes drugs, hepatitis drugs, antibiotics, osteoarthritis drugs, anti-inflammatory drugs, nootropics, epilepsy drugs, smoking cessation aid drugs and others, as well as over-the-counter (OTC) drugs.